APA (7th ed.) Citation

M, H., M, K., GC, H., D, L., LG, A., HA, S., . . . RB, C. (2018). Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in BRAFV600E Colorectal Cancer. Cancer discovery, 8(4), 417. https://doi.org/10.1158/2159-8290.CD-17-1227

Chicago Style (17th ed.) Citation

M, Hazar-Rethinam, et al. "Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in BRAFV600E Colorectal Cancer." Cancer Discovery 8, no. 4 (2018): 417. https://doi.org/10.1158/2159-8290.CD-17-1227.

MLA (9th ed.) Citation

M, Hazar-Rethinam, et al. "Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in BRAFV600E Colorectal Cancer." Cancer Discovery, vol. 8, no. 4, 2018, p. 417, https://doi.org/10.1158/2159-8290.CD-17-1227.